Innovid is providing the following financial guidance for Q4 and updating its full year 2024 guidance: Q4 2024 revenue in a ...

JMP Securities analyst Matthew Condon reiterated a Buy rating on Innovid (CTV – Research Report) today and set a price target of $3.00. The company’s shares closed yesterday at $1.81. According to ...

Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ETCompany ParticipantsLauren Hartman - Investor RelationsZvika Netter ...

Morgan Stanley analyst Matthew Cost maintained a Hold rating on Innovid (CTV – Research Report) today and set a price target of $2.25.

Innovid Corp (CTV) reports a 6% revenue growth and expands its partnership with Netflix, while navigating challenges from political ad spending and a shift to a software-only model.

Chartis Research, part of Infopro Digital, is a leading provider of research and... Innovid Corp. , an independent software platform for the creation, delivery, measurement, and optimization of ...

Zucara Therapeutics Inc., ("Zucara" or the "Company") a diabetes life sciences company developing ZT-01, the first once-daily therapeutic to prevent ...

At close: November 8 at 4:00 PM EST ...

Innovid Corp. (NYSE:CTV), an independent software platform for the creation, delivery, measurement, and optimization of advertising across connected TV (CTV), linear TV, and digital, today announced ...

The ad industry is all in on generative AI, a buzzword that makes data clean rooms or blockchain look quaint. But for the ...